TX-1501

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTX-1501

Drug Alias Namerecombinant LDL receptor-transferrin fusion protein (TKT)LDLR/TFrecombinant LDL receptor-transferrin fusion protein (Shire Human Genetic Therapies)TX-1501

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTransferrins modulators

TargetsTransferrins

Therapy Area/IndicationsHyperlipoproteinemia Type II

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesShire Human Genetic Therapies, Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShire Human Genetic Therapies, Inc

Active IndicationsN/A

Inactive IndicationsHyperlipoproteinemia Type II

Other Information

ATC CodeN/A